Literature DB >> 18973842

Liver biopsy.

P Bedossa1.   

Abstract

Fibrosis, the excess deposition of extracellular matrix in the liver is a form of anatomical damage to the liver parenchyma, so that liver biopsy is the only approach for its direct assessment. Although liver biopsy has its limitations, appropriate precautions can reduce the flaws inherent in this method. The level of accuracy obtained with biopsy is particularly important for obtaining a starting point in patients with chronic liver disease who are to be followed-up over a number of years. Therefore, liver biopsy has been used as the gold standard to establish algorithm combinations of biological tests. As well as an accurate assessment of the extent of liver fibrosis, the biopsy can reveal other informations and associated features relevant to evaluation of the fibrotic process.

Entities:  

Mesh:

Year:  2008        PMID: 18973842     DOI: 10.1016/S0399-8320(08)73989-7

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN: 0399-8320


  8 in total

1.  An update on the management of hepatitis C: consensus guidelines from the Canadian Association for the Study of the Liver.

Authors:  Robert P Myers; Alnoor Ramji; Marc Bilodeau; Stephen Wong; Jordan J Feld
Journal:  Can J Gastroenterol       Date:  2012-06       Impact factor: 3.522

2.  The 3D EdgeRunner Pipeline: A Novel Shape-Based Analysis for Neoplasms Characterization.

Authors:  Fernando Yepes-C; Rebecca Johnson; Darryl Hwang; Julie Coloigner; Felix Yap; Desai Bushan; Phillip Cheng; Inderbir Gill; Vinay Duddalwar; Natasha Lepore
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2016-03-29

3.  An update on the management of chronic hepatitis C: 2015 Consensus guidelines from the Canadian Association for the Study of the Liver.

Authors:  Robert P Myers; Hemant Shah; Kelly W Burak; Curtis Cooper; Jordan J Feld
Journal:  Can J Gastroenterol Hepatol       Date:  2015-01-13

Review 4.  Practical management of the increasing burden of non-alcoholic fatty liver disease.

Authors:  Angelina Mouralidarane; Ching-I Lin; Narin Suleyman; Junpei Soeda; Jude A Oben
Journal:  Frontline Gastroenterol       Date:  2010-09-23

5.  Evaluation of Risk Factors for Bleeding After Ultrasound-Guided Liver Biopsy.

Authors:  Haoyu Jing; Zhanxiong Yi; Enhui He; Ruifang Xu; Xianquan Shi; Li Li; Liying Sun; Ying Liu; Liang Zhang; Linxue Qian
Journal:  Int J Gen Med       Date:  2021-09-11

Review 6.  Chronic hepatitis C virus infection: Serum biomarkers in predicting liver damage.

Authors:  Pamela Valva; Daniela A Ríos; Elena De Matteo; Maria V Preciado
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

7.  Performance of real-time elastography for the staging of hepatic fibrosis: a meta-analysis.

Authors:  Huisuo Hong; Jia Li; Yin Jin; Qiao Li; Weimin Li; Jiansheng Wu; Zhiming Huang
Journal:  PLoS One       Date:  2014-12-26       Impact factor: 3.240

8.  A non-invasive model for predicting liver fibrosis in HBeAg-positive patients with normal or slightly elevated alanine aminotransferase.

Authors:  Ling Li; Yongan Ye; Yun Ran; Shuyan Liu; Qiyuan Tang; Yaya Liu; Xuejiao Liao; Juanjuan Zhang; Guohui Xiao; Jian Lu; Guoliang Zhang; Qing He; Shiping Hu
Journal:  Medicine (Baltimore)       Date:  2021-04-30       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.